Tectonic Therapeutic (TECX) Other Non Operating Income (2017 - 2026)
Tectonic Therapeutic's (TECX) quarterly Other Non Operating Income came in at -$113000.0 in Q1 2026, down 253.12% year-on-year from $73795.9 in Q1 2025, and down 102.67% on a QoQ basis from $4.2 million in Q4 2025.
Tectonic Therapeutic (TECX) Other Non Operating Income (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 9 years of Other Non Operating Income data on file, last reported at -$113000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 253.12% year-over-year to -$113000.0 in Q1 2026; TTM through Mar 2026 was $4.0 million, a 3010.79% increase from a year earlier, with the FY2025 full-year figure at $4.1 million, up 907.63% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$113000.0, down from $4.2 million in the prior quarter.
- Over the last five years, Other Non Operating Income for TECX reached as high as $4.2 million in Q4 2025 and fell as low as -$403000.0 in Q1 2024.
- Historically, Other Non Operating Income has averaged $236312.5 across 5 years, with a median of -$19500.0 in 2023.
- Across the five-year window, Other Non Operating Income sank 2786.67% in 2024 and jumped 4561.05% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at -$95000.0 in 2022, then soared by 527.37% to $406000.0 in 2023, then slumped by 123.4% to -$95000.0 in 2024, then soared by 4561.05% to $4.2 million in 2025, then slumped by 102.67% to -$113000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$113000.0 in Q1 2026, $4.2 million in Q4 2025, and -$31000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -113,000.00 |
| Dec 31, 2025 | 4.24 Mn |
| Sep 30, 2025 | -31,000.00 |
| Jun 30, 2025 | -48,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Dec 31, 2024 | -95,000.00 |
| Sep 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -403,000.00 |
| Dec 31, 2023 | 406,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -8,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Sep 30, 2022 | -95,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | -45,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | -21,000.00 |
| Sep 30, 2020 | -74,000.00 |
| Jun 30, 2018 | -1.04 Mn |